Peptidia Research
The evidence is the product.
Dose-free peptide evidence previews, research-literacy guides, and transparent product comparisons. Every page names its limits, links its sources, and carries a real editorial-review date.
Reviewed evidence previews
Start with what the strongest evidence actually found.
Only editor-approved records are public. These are concise previews, not the full subscriber library.
Evidence Passport preview
Ipamorelin
Ipamorelin is a synthetic peptide that activates the ghrelin receptor and stimulates endogenous growth-hormone release. Its selectivity is documented mainly in preclinical studies. The strongest controlled human trial, in postoperative ileus, did not show a significant benefit on its key or secondary efficacy outcomes, and marketed wellness claims remain unproven.
4 inspectable sources · Reviewed August 2026
Evidence Passport preview
AOD-9604
AOD-9604 is a synthetic fragment based on the end region of human growth hormone. Animal studies supported a fat-metabolism hypothesis, but the human development program did not establish meaningful weight-loss efficacy and was discontinued. It is not approved as a treatment for obesity or another clinical condition.
4 inspectable sources · Reviewed August 2026
Evidence Passport preview
Selank
Selank is a synthetic peptide derived from tuftsin and developed in Russia. Limited human studies report anxiety-related and neuroimaging signals, but the evidence base is small and geographically concentrated; most proposed mechanisms are preclinical. It is not approved by the U.S. Food and Drug Administration or Health Canada.
4 inspectable sources · Reviewed August 2026
Research literacy
A better filter for the next claim you encounter.
Guide
How to evaluate peptide research without getting lost in the hype
A repeatable method for checking peptide claims: identify the evidence type, population, outcome, comparator, limitations, and regulatory context.
8 min · 4 sources
Guide
What preclinical evidence means—and what it cannot tell you
A plain-language guide to cell, animal, and mechanistic peptide research, the translation gap, and the questions to ask before extrapolating to people.
7 min · 4 sources
Guide
Citations vs evidence quality: why a long reference list is not enough
Learn how to move from citation count to study design, directness, bias, precision, consistency, and applicability.
7 min · 3 sources
Guide
How to read a ClinicalTrials.gov record without overclaiming
A field-by-field guide to study status, sponsor, design, outcomes, enrollment, posted results, and record history.
8 min · 3 sources
Guide
Randomized controlled trials explained for peptide research
Understand randomization, control groups, blinding, prespecified outcomes, attrition, and why trial design still needs interpretation.
8 min · 3 sources
Guide
Systematic reviews explained: what makes a synthesis trustworthy?
Learn how a systematic review differs from a narrative overview and how to inspect its question, search, selection, bias assessment, synthesis, and certainty.
8 min · 4 sources
Guide
Biomarkers vs clinical outcomes: what did the study actually change?
Understand the difference between a biological measurement, a surrogate endpoint, and an outcome that directly reflects how people feel, function, or survive.
7 min · 3 sources
Guide
Statistical significance vs practical importance in research
Learn why a threshold-based result does not reveal effect size, precision, clinical relevance, bias, or the full evidence context.
7 min · 3 sources
Guide
Sample size and study power: why small studies mislead
Understand precision, events, variability, statistical power, and why a small positive or negative study rarely settles a peptide claim.
7 min · 3 sources
Guide
Conflicts of interest in peptide research: how to read them
A practical method for examining funding, author relationships, sponsor control, analysis, reporting, and replication without dismissing evidence by association.
8 min · 3 sources
Guide
Regulatory approval vs evidence: four distinctions that matter
Understand the difference between being studied, authorized for research, approved for a specific use, compounded, and promoted online.
8 min · 3 sources
Guide
Compounded peptides and evidence: product quality is a separate question
Learn why published molecule research, regulatory approval, compounding standards, and the identity of a specific preparation must be evaluated separately.
8 min · 3 sources
Guide
WADA and peptide research in 2026: what athletes need to verify
A research-focused guide to the World Anti-Doping Agency prohibited list, jurisdiction, in-competition rules, and current verification.
7 min · 3 sources
Guide
Peptidia’s Source Strength Score: what it says and what it cannot say
A transparent explanation of evidence tiers, directness, study quality, consistency, and why no single score can replace reading the sources.
7 min · 3 sources
Guide
Why negative trials matter in peptide research
Learn how a well-designed negative study updates an evidence record, why absence of significance is not always proof of no effect, and why unfavorable findings are easy to miss.
7 min · 3 sources
Guide
Research freshness and review dates: when an evidence page goes stale
A practical standard for search cutoffs, editorial review dates, regulatory checks, corrections, retractions, and rapidly changing evidence.
7 min · 4 sources
Guide
The Peptidia Evidence Passport: a field guide
Understand the evidence-maturity label, source strength, uncertainty, negative findings, review date, and boundaries shown on Peptidia profiles.
7 min · 4 sources
Product decisions
Comparisons with the conflict visible.
Peptidia is not a neutral observer in pages that compare Peptidia. We say that clearly, date every product review, and link the official listings behind each claim.
Comparison
Best peptide research apps in 2026: choose by the job you need done
A transparent comparison of peptide research apps for evidence review, broad reference, and private tracking—based on current official product listings.
7 min · Methodology disclosed
Comparison
Peptidia vs PepPedia in 2026: evidence interface or all-in-one toolkit?
An evidence-first comparison of Peptidia and PepPedia, including who each app is for, what their public listings emphasize, and the tradeoffs.
6 min · Methodology disclosed
Alternatives
PepPedia alternatives in 2026: three different ways to research peptides
Alternatives to PepPedia for evidence inspection, personal tracking, or a direct-source workflow using PubMed and ClinicalTrials.gov.
6 min · Methodology disclosed
Comparison
Peptidia vs PeptidePal in 2026: evidence research or tracking workflow?
A transparent comparison of Peptidia and PeptidePal based on their official listings, primary jobs, evidence posture, and personal-record features.
6 min · Methodology disclosed
Comparison
PepPedia vs PeptidePal in 2026: broad reference or tracker-first app?
A source-linked comparison of PepPedia and PeptidePal, with Peptidia included as an evidence-first third option.
6 min · Methodology disclosed
Comparison
Peptidia vs PubMed in 2026: evidence summary or literature database?
Understand when to use Peptidia’s editorial summaries and when to search PubMed’s biomedical literature database directly.
6 min · Methodology disclosed
Comparison
Peptidia vs ClinicalTrials.gov in 2026: editorial context or trial record?
A practical guide to using Peptidia alongside ClinicalTrials.gov without confusing a registered study with a completed positive result.
6 min · Methodology disclosed
Alternatives
PeptidePal alternatives in 2026: five options for different jobs
Compare PeptidePal alternatives for evidence research, broad reference, journaling, and tracking using official product listings.
8 min · Methodology disclosed
Comparison
Best peptide tracking apps in 2026: compare the tracking job first
A transparent 2026 comparison of tracker-first peptide apps, plus the evidence-first alternative for readers who primarily need research context.
8 min · Methodology disclosed
Comparison
Best peptide journal apps in 2026: private records without evidence confusion
Compare peptide journal and tracking apps by privacy, export, research context, and the difference between observations and evidence.
7 min · Methodology disclosed
Comparison
Best peptide research tools in 2026: a complete evidence workflow
Build a peptide research workflow with Peptidia, PubMed, ClinicalTrials.gov, FDA resources, and systematic-review guidance.
8 min · Methodology disclosed
Alternatives
Peptide tracker alternatives in 2026: research, journals, or simple records?
Alternatives to a dedicated peptide tracker, including evidence-first research, broader journals, and privacy-conscious record choices.
7 min · Methodology disclosed
Alternatives
Peptide calculator alternatives in 2026: when research is the real need
A safety-first look at alternatives to peptide calculator apps, including evidence resources and qualified clinical support.
7 min · Methodology disclosed
Full iPhone experience
Sources, uncertainty, and review dates—wherever you research.
The Peptidia app adds the complete reviewed library, inspectable study cards, grounded questions, and a private wellness journal.
Educational information only. Not medical advice. No personalized recommendations or numeric doses are provided. Peptidia does not sell peptides or endorse vendors.